These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34746282)

  • 1. Novel Approach to Assess Cardiac Function Using Systolic Performance and Myocardial Performance Indices From Simultaneous Electrocardiography and Phonocardiography Recordings in Dogs With Various Stages of Myxomatous Mitral Valve Disease.
    Gicana KRB; Lertwanakarn T; Tachampa K
    Front Vet Sci; 2021; 8():741115. PubMed ID: 34746282
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of proposed systolic and myocardial performance indices derived from simultaneous ECG and PCG recordings to assess cardiac function in healthy Beagles.
    Gicana KRB; Pinidmontree C; Kosalathip K; Sirirut S; Komolvanich S; Asawakarn S; Sakcamduang W; Naiyanetr P; Tachampa K
    Vet World; 2022 Jul; 15(7):1785-1797. PubMed ID: 36185531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Right Ventricular Tei Index in Dogs with Myxomatous Mitral Valvular Heart Disease.
    Nakamura K; Morita T; Osuga T; Morishita K; Sasaki N; Ohta H; Takiguchi M
    J Vet Intern Med; 2016; 30(1):69-75. PubMed ID: 26789419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echocardiographic Estimates of Right Ventricular Systolic Function in Dogs with Myxomatous Mitral Valve Disease.
    Chapel EH; Scansen BA; Schober KE; Bonagura JD
    J Vet Intern Med; 2018 Jan; 32(1):64-71. PubMed ID: 29224256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental predictive value of echocardiographic indices of right ventricular function in the assessment of long-term prognosis in dogs with myxomatous mitral valve disease.
    Morita T; Nakamura K; Osuga T; Takiguchi M
    J Vet Cardiol; 2022 Feb; 39():51-62. PubMed ID: 34979482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac time intervals by tissue Doppler imaging M-mode echocardiography: reproducibility, reference values, association with clinical characteristics and prognostic implications.
    Biering-Sørensen T
    Dan Med J; 2016 Aug; 63(8):. PubMed ID: 27477801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Proteomic Profiles Reflect the Stages of Myxomatous Mitral Valve Disease in Dogs.
    Rešetar Maslov D; Farkaš V; Rubić I; Kuleš J; Beletić A; Beer Ljubić B; Šmit I; Mrljak V; Torti M
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of conventional and tissue Doppler echocardiography to predict congestive heart failure in dogs with myxomatous mitral valve disease.
    Kim JH; Park HM
    J Vet Intern Med; 2015 Jan; 29(1):132-40. PubMed ID: 25270196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of electrocardiographic parameters in dogs with different stages of myxomatous mitral valve disease.
    Na Y; Lee D; Yun T; Koo Y; Chae Y; Kim H; Yang MP; Kang BT
    Can J Vet Res; 2021 Oct; 85(4):261-270. PubMed ID: 34602730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitral valve morphology assessed by three-dimensional transthoracic echocardiography in healthy dogs and dogs with myxomatous mitral valve disease.
    Menciotti G; Borgarelli M; Aherne M; Wesselowski S; Häggström J; Ljungvall I; Lahmers SM; Abbott JA
    J Vet Cardiol; 2017 Apr; 19(2):113-123. PubMed ID: 28279678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of heart rate turbulence in dogs with myxomatous mitral valve disease.
    Dos Santos JP; Lucina SB; da Costa BN; Olaguivel KLC; Tuleski GLR; Sousa MG
    Open Vet J; 2021; 11(4):635-644. PubMed ID: 35070858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pimobendan on myocardial perfusion and pulmonary transit time in dogs with myxomatous mitral valve disease: a pilot study.
    Apple SM; Menciotti G; Braz-Ruivo L; Crosara S; Häggström J; Borgarelli M
    Aust Vet J; 2016 Sep; 94(9):324-8. PubMed ID: 27569835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left atrial volume and function in dogs with naturally occurring myxomatous mitral valve disease.
    Höllmer M; Willesen JL; Tolver A; Koch J
    J Vet Cardiol; 2017 Feb; 19(1):24-34. PubMed ID: 27825670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
    Rasmussen CE; Falk T; Zois NE; Moesgaard SG; Häggström J; Pedersen HD; Ablad B; Nilsen HY; Olsen LH
    J Vet Intern Med; 2012; 26(1):76-84. PubMed ID: 22151356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT instability, an indicator of augmented arrhythmogenesis, increases with the progression of myxomatous mitral valve disease in dogs.
    Brüler BC; Jojima FS; Dittrich G; Giannico AT; Sousa MG
    J Vet Cardiol; 2018 Aug; 20(4):254-266. PubMed ID: 30031743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-wave peak-end interval and ratio of T-wave peak-end and QT intervals: novel arrhythmogenic and survival markers for dogs with myxomatous mitral valve disease.
    Vila BCP; Camacho AA; Sousa MG
    J Vet Cardiol; 2021 Jun; 35():25-41. PubMed ID: 33812131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary intervention reduces left atrial enlargement in dogs with early preclinical myxomatous mitral valve disease: a blinded randomized controlled study in 36 dogs.
    Li Q; Heaney A; Langenfeld-McCoy N; Boler BV; Laflamme DP
    BMC Vet Res; 2019 Nov; 15(1):425. PubMed ID: 31775756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil improves heart rate variability in dogs with asymptomatic myxomatous mitral valve degeneration.
    Pirintr P; Saengklub N; Limprasutr V; Sawangkoon S; Kijtawornrat A
    J Vet Med Sci; 2017 Sep; 79(9):1480-1488. PubMed ID: 28717064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs.
    Ljungvall I; Höglund K; Lilliehöök I; Oyama MA; Tidholm A; Tvedten H; Häggström J
    J Vet Intern Med; 2013; 27(5):1105-12. PubMed ID: 23865457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Dysbiosis and Its Associations with Gut Microbiota-Derived Metabolites in Dogs with Myxomatous Mitral Valve Disease.
    Li Q; Larouche-Lebel É; Loughran KA; Huh TP; Suchodolski JS; Oyama MA
    mSystems; 2021 Apr; 6(2):. PubMed ID: 33879495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.